ModifiedBlue Cross Blue Shield - MassachusettsPolicy 141

Transcatheter catheter ablation (RFA, cryoablation, pulsed field) for atrial fibrillation

Defines medical necessity, indications, repeat-procedure limits, investigational exclusions, coding guidance, and prior authorization requirements for transcatheter radiofrequency ablation, cryoablation, and pulsed field ablation to treat atrial fibrillation for Commercial and Medicare products.

Policy Summary

PayerBlue Cross Blue Shield - Massachusetts

PolicyTranscatheter catheter ablation (RFA, cryoablation, pulsed field) for atrial fibrillation

Policy CodePolicy 141

Change TypeMEDICALLY NECESSARY statements added for PFAliterature update

Effective DateNov 1, 2009

Next Review Date

Key ActionPrecertification/preauthorization IS REQUIRED for all products if the procedure is performed inpatient.

SourceLink

POLICY UPDATE CHANGES

Policy updated with literature review through December 9, 2024; effective 8/1/2025.

References added and description/summary updated; reflects inclusion of evidence for PFA.

Repeat procedures guidance retained and clarified in policy history earlier (2009-2015) and reiterated.

3Allowed repeat procedures

93656,93657Key CPT codes

I48.x,I50.xPrimary ICD-10 groups

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

PFA added 2025PFA coverage status

Coverage Summary

This policy defines medical necessity criteria for transcatheter catheter ablation — including radiofrequency ablation (RFA), cryoablation, and pulsed field ablation (PFA) — for treatment of atrial fibrillation. It covers indications (symptomatic paroxysmal or persistent AF, an alternative indication in selected heart failure patients, and selected first-line use for recurrent paroxysmal AF), a limit of up to 3 repeat transcatheter ablations as medically necessary when criteria are met, and investigational/not medically necessary exclusions when cases do not meet the listed criteria. Precertification/authorization rules and coding guidance are summarized below. PFA was added to medically necessary policy statements effective 8/1/2025 based on literature review and clinical input.

Surface thresholds and quick facts

Allowed repeat procedures3

Key CPT codes93656, 93657

Primary ICD-10 diagnosis groupsI48.x (atrial fibrillation/flutter), I50.x (heart failure)

Pulsed field ablation coverage statusPFA added 2025 (medically necessary statements added effective 8/1/2025)

Medical-Necessity Criteria

Medically Necessary Indications

Transcatheter RFA, cryoablation or pulsed field ablation is MEDICALLY NECESSARY when ALL of the following apply:

Procedure type: Procedure is transcatheter radiofrequency ablation (RFA), cryoablation, or pulsed field ablation to treat atrial fibrillation (may include pulmonary vein isolation and/or focal ablation).
See policy: pulsed field ablation added as medically necessary per 8/1/2025.
AF type and coding: Member has symptomatic paroxysmal or symptomatic persistent atrial fibrillation.
Relevant ICD-10 codes include I48.0, I48.11, I48.19, I48.20, I48.21, I48.91 (paroxysmal/persistent/permanent and unspecified AF) and atrial flutter codes I48.3, I48.4, I48.92; submit appropriate ICD-10 diagnosis code(s) with CPT codes 93656/93657.
Prior therapy requirement:

Coding

Covered CPT Codes (when medical necessity criteria met)CPTCovered

93656

Comprehensive electrophysiologic evaluation with transseptal catheterizations, insertion and repositioning of multiple electrode catheters, induction or attempted induction of an arrhythmia including left or right atrial pacing/recording, and intracardiac catheter ablation of atrial fibrillation by pulmonary vein isolation, including intracardiac electrophysiologic 3-dimensional mapping, intracardiac echocardiography with imaging supervision and interpretation, right ventricular pacing/recording, and His bundle recording, when performed.

93657

Additional linear or focal intracardiac catheter ablation of the left or right atrium for treatment of atrial fibrillation remaining after completion of pulmonary vein isolation (List separately in addition to code for primary procedure).

Associated ICD-10 Diagnosis Codes (considered medically necessary when submitted with above CPTs and criteria met)ICD-10Covered

I48.0	Paroxysmal atrial fibrillation
I48.11	Longstanding persistent atrial fibrillation
I48.19	Other persistent atrial fibrillation
I48.20	Chronic atrial fibrillation, unspecified
I48.21	Permanent atrial fibrillation
I48.3	Typical atrial flutter
I48.4	Atypical atrial flutter
I48.91	Unspecified atrial fibrillation
I48.92	Unspecified atrial flutter
I50.20	Unspecified systolic (congestive) heart failure

1–10 of 22

1/3

When submitting claims, providers must include appropriate ICD-10 diagnosis code(s) listed in the policy with CPT codes 93656 and 93657 as documentation of medical necessity, and should report services using the most up-to-date procedure, revenue, and diagnosis codes and modifiers.

Provider Actions

Prior Authorization

Inpatient precertification required

Precertification/preauthorization IS REQUIRED for all products if the procedure is performed inpatient.

Prior Authorization

Outpatient prior authorization not required for listed products

For Commercial Managed Care (HMO and POS), Commercial PPO and Indemnity, Medicare HMO Blue and Medicare PPO Blue, prior authorization is not required for outpatient procedures.

Documentation Required

Medical necessity documentation required

Clinical documentation must demonstrate symptomatic paroxysmal or persistent atrial fibrillation, prior adequate trials of antiarrhythmic medications (unless meeting the heart failure alternative or first-line recurrent paroxysmal criteria), or other covered indication; submit appropriate ICD-10 diagnosis code(s) with CPT codes 93656/93657.

Background

Catheter-based ablation techniques target arrhythmogenic foci, most commonly near the pulmonary veins, using percutaneous catheters. Traditional approaches include radiofrequency ablation (RFA) with circumferential pulmonary vein isolation and cryoablation (eg, cryoballoon) that can allow a one-shot anatomic approach. Pulsed field ablation (PFA) is a newer technique that delivers brief electrical pulses and has been recently approved in the US. Ablation is used for rhythm control and may be offered as an alternative to atrioventricular nodal ablation with pacemaker implantation in selected patients with heart failure. Repeat ablation procedures are commonly performed for recurrent AF or new atrial flutter and are generally more limited in scope than the initial procedure.

Evidence from randomized trials and systematic reviews supports that RFA and cryoablation are effective for drug-refractory symptomatic paroxysmal and persistent atrial fibrillation and improve net health outcomes. Randomized controlled trials of PFA have demonstrated noninferiority to thermal ablation for short-term effectiveness and safety, but evidence is insufficient to determine whether PFA improves long-term net health outcomes.

Definitions

Recurrent symptomatic paroxysmal atrial fibrillation: >1 episode, with 4 or fewer episodes in the previous 6 months (eligibility criterion for initial/first-line ablation when a rhythm-control strategy is desired).

Revision History

8/1/2025material change - addedLatest

Policy updated with literature review through December 9, 2024; effective 8/1/2025.

8/1/2025material change - addedLatest

Medically necessary policy statements added for pulsed field ablation based on review of clinical input.

2025 (annual review)

Policy Summary

PayerBlue Cross Blue Shield - Massachusetts

PolicyTranscatheter catheter ablation (RFA, cryoablation, pulsed field) for atrial fibrillation

Policy CodePolicy 141

Change TypeMEDICALLY NECESSARY statements added for PFAliterature update

Effective DateNov 1, 2009

Next Review Date

Key ActionPrecertification/preauthorization IS REQUIRED for all products if the procedure is performed inpatient.

SourceLink

On This Page

Atrial fibrillation has failed to respond to adequate trials of antiarrhythmic medications.

Exception: the prior antiarrhythmic medication requirement does not apply when the alternative heart-failure indication or the defined first-line recurrent paroxysmal criteria are met.

Alternative Medically Necessary Indication (Heart Failure)

Covered as alternative when ALL of the following are met:

Alternative to AV nodal ablation+pacemaker: Used as an alternative to atrioventricular nodal ablation and pacemaker insertion.
Heart failure and symptomatic AF: Individual has class II or III congestive heart failure and symptomatic atrial fibrillation.
Relevant ICD-10 heart failure codes include I50.x when submitted with CPT 93656/93657.

Initial Therapy (first-line) - Selected Cases

Covered as initial treatment when ALL of the following are met:

Recurrent symptomatic paroxysmal AF: Individual has recurrent symptomatic paroxysmal atrial fibrillation.>1 episode, with 4 or fewer episodes in the previous 6 months
Threshold definition from policy: eligibility for first-line ablation when rhythm-control strategy desired.
Treatment strategy desired: A rhythm-control strategy is desired by the clinician and/or patient.
First-line ablation permitted only for selected recurrent paroxysmal AF per threshold above.

Repeat Procedures

Up to 3 repeat transcatheter ablations may be MEDICALLY NECESSARY when the following are met:

Recurrence or flutter: Recurrence of atrial fibrillation and/or development of atrial flutter following the initial procedure.
Clinical rationale supports repeat procedure (scope generally more limited than initial procedure).
Policy limit: Up to 3 repeat transcatheter ablations may be MEDICALLY NECESSARY.

Investigational / Not Medically Necessary

Transcatheter RFA, cryoablation, and pulsed field ablation is considered INVESTIGATIONAL when ANY of the following apply:

Does not meet medically necessary criteria: Atrial fibrillation case does not meet the specific criteria outlined in the medically necessary sections above.
Such cases are considered investigational / not medically necessary per policy.

Affected CPT codes: 93656, 93657
Required documentation elements:
- Evidence of symptomatic paroxysmal or persistent atrial fibrillation
- Prior adequate trials of antiarrhythmic medications unless the heart-failure alternative or first-line recurrent paroxysmal criteria apply
- Appropriate ICD-10 diagnosis code(s) submitted with CPT 93656/93657 (see I48.x, I50.x)

Billing Rule

Report most up-to-date codes and modifiers

Providers should report all services using the most up-to-date industry-standard procedure, revenue, and diagnosis codes, including modifiers where applicable.

non-material annual review

Annual policy review with literature updates and references added (through Dec 9, 2024).

12/2009material clarification

Clarified repeat procedure allowance: up to 3 repeat transcatheter ablations may be considered medically necessary.